Silencing the shutoff protein of Epstein–Barr virus in productively infected B cells points to (innate) targets for immune evasion

Journal of General Virology

Volumn 96, Issue 4, 2015, Pages 858-865

  Van Gent, Michiel ^a   Gram, Anna M ^a,b   Boer, Ingrid G J ^a   Geerdink, Ruben J ^a   Lindenbergh, Marthe F S ^a   Jan Lebbink, Robert ^a   Wiertz, Emmanuel J ^a   Ressing, Maaike E ^a,b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BGLF5 PROTEIN; CD103 ANTIGEN; CD19 ANTIGEN; CD1D ANTIGEN; CD20 ANTIGEN; CD38 ANTIGEN; CD45 ANTIGEN; CD47 ANTIGEN; CELL PROTEIN; GAMMA INTERFERON RECEPTOR 1; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 3; MESSENGER RNA; SHORT HAIRPIN RNA; TOLL LIKE RECEPTOR 2; UNCLASSIFIED DRUG; VIRUS PROTEIN; DEOXYRIBONUCLEASE; DEOXYRIBONUCLEASE, EPSTEIN-BARR VIRUS; TOLL LIKE RECEPTOR;

ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; DOWN REGULATION; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; GENE EXPRESSION; GENE SILENCING; IMMUNE EVASION; INNATE IMMUNITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STABLE EXPRESSION; VIRUS GENE; VIRUS LATENCY; VIRUS REACTIVATION; VIRUS REPLICATION; CELL LINE; GENETICS; HUMAN; IMMUNOLOGY; VIROLOGY;

HUMAN HERPESVIRUS 4;

ANTIGENS, CD1D; B-LYMPHOCYTES; CELL LINE; DEOXYRIBONUCLEASES; EPSTEIN-BARR VIRUS INFECTIONS; HERPESVIRUS 4, HUMAN; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; IMMUNE EVASION; IMMUNITY, INNATE; TOLL-LIKE RECEPTORS; VIRAL PROTEINS; VIRUS REPLICATION;

EID: 84924943115     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/jgv.0.000021     Document Type: Article

References (38)

1. Barnes, P. D. & Grundy, J. E. (1992). Down-regulation of the class I HLA heterodimer and b2-microglobulin on the surface of cells infected with cytomegalovirus. J Gen Virol 73, 2395–2403.
2. Clyde, K. & Glaunsinger, B. A. (2011). Deep sequencing reveals direct targets of gammaherpesvirus-induced mRNA decay and suggests that multiple mechanisms govern cellular transcript escape. PLoS ONE 6, e19655.
3. Covarrubias, S., Richner, J. M., Clyde, K., Lee, Y. J. & Glaunsinger, B. A. (2009). Host shutoff is a conserved phenotype of gammaherpesvirus infection and is orchestrated exclusively from the cytoplasm. J Virol 83, 9554–9566.
4. Delecluse, H. J., Feederle, R., Behrends, U. & Mautner, J. (2008). Contribution of viral recombinants to the study of the immune response against the Epstein-Barr virus. Semin Cancer Biol 18, 409–415.
5. El-Guindy, A., Lopez-Giraldez, F., Delecluse, H. J., McKenzie, J. & Miller, G. (2014). A locus encompassing the Epstein-Barr virus bglf4 kinase regulates expression of genes encoding viral structural proteins. PLoS Pathog 10, e1004307.
6. Feederle, R., Bannert, H., Lips, H., Müller-Lantzsch, N. & Delecluse, H. J. (2009a). The Epstein-Barr virus alkaline exonuclease BGLF5 serves pleiotropic functions in virus replication. J Virol 83, 4952–4962.
7. Feederle, R., Mehl-Lautscham, A. M., Bannert, H. & Delecluse, H. J. (2009b). The Epstein-Barr virus protein kinase BGLF4 and the exonuclease BGLF5 have opposite effects on the regulation of viral protein production. J Virol 83, 10877–10891.
8. Feng, P., Moses, A. & Früh, K. (2013). Evasion of adaptive and innate immune response mechanisms by c-herpesviruses. Curr Opin Virol 3, 285–295.
9. Gaglia, M. M., Covarrubias, S., Wong, W. & Glaunsinger, B. A. (2012). A common strategy for host RNA degradation by divergent viruses. J Virol 86, 9527–9530.
10. Gaudreault, E., Fiola, S., Olivier, M. & Gosselin, J. (2007). Epstein-Barr virus induces MCP-1 secretion by human monocytes via TLR2. J Virol 81, 8016–8024.
11. Glaunsinger, B. & Ganem, D. (2004). Lytic KSHV infection inhibits host gene expression by accelerating global mRNA turnover. Mol Cell 13, 713–723.
12. Griffin, B. D., Verweij, M. C. & Wiertz, E. J. H. J. (2010). Herpesviruses and immunity: the art of evasion. Vet Microbiol 143, 89–100.
13. Horst, D., van Leeuwen, D., Croft, N. P., Garstka, M. A., Hislop, A. D., Kremmer, E., Rickinson, A. B., Wiertz, E. J. H. J. & Ressing, M. E. (2009). Specific targeting of the EBV lytic phase protein BNLF2a to the transporter associated with antigen processing results in impairment of HLA class I-restricted antigen presentation. J Immunol 182, 2313–2324.
14. Horst, D., Geerdink, R. J., Gram, A. M., Stoppelenburg, A. J. & Ressing, M. E. (2012a). Hiding lipid presentation: viral interference with CD1d-restricted invariant natural killer T (iNKT) cell activation. Viruses 4, 2379–2399.
15. Horst, D., Burmeister, W. P., Boer, I. G. J., van Leeuwen, D., Buisson, M., Gorbalenya, A. E., Wiertz, E. J. H. J. & Ressing, M. E. (2012b). The “bridge” in the Epstein-Barr virus alkaline exonuclease protein BGLF5 contributes to shutoff activity during productive infection. J Virol 86, 9175–9187.
16. Iwakiri, D., Zhou, L., Samanta, M., Matsumoto, M., Ebihara, T., Seya, T., Imai, S., Fujieda, M., Kawa, K. & Takada, K. (2009). Epstein-Barr virus (EBV)-encoded small RNA is released from EBV-infected cells and activates signaling from Toll-like receptor 3. J Exp Med 206, 2091–2099.
17. Iwasaki, A. & Medzhitov, R. (2010). Regulation of adaptive immunity by the innate immune system. Science 327, 291–295.
18. Jones, T. R., Hanson, L. K., Sun, L., Slater, J. S., Stenberg, R. M. & Campbell, A. E. (1995). Multiple independent loci within the human cytomegalovirus unique short region down-regulate expression of major histocompatibility complex class I heavy chains. J Virol 69, 4830–4841.
19. Kinjo, Y., Kitano, N. & Kronenberg, M. (2013). The role of invariant natural killer T cells in microbial immunity. J Infect Chemother 19, 560–570.
20. Koppers-Lalic, D., Rychlowski, M., van Leeuwen, D., Rijsewijk, F. A. M., Ressing, M. E., Neefjes, J. J., Bienkowska-Szewczyk, K. & Wiertz, E. J. H. J. (2003). Bovine herpesvirus 1 interferes with TAPdependent peptide transport and intracellular trafficking of MHC class I molecules in human cells. Arch Virol 148, 2023–2037.
21. Kurt-Jones, E. A., Mandell, L., Whitney, C., Padgett, A., Gosselin, K., Newburger, P. E. & Finberg, R. W. (2002). Role of Toll-like receptor 2 (TLR2) in neutrophil activation: GM-CSF enhances TLR2 expression and TLR2-mediated interleukin 8 responses in neutrophils. Blood 100, 1860–1868.
22. Lebbink, R. J., Lowe, M., Chan, T., Khine, H., Wang, X. & McManus, M. T. (2011). Polymerase II promoter strength determines efficacy of microRNA adapted shRNAs. PLoS ONE 6, e26213.
23. Murphy, J. A., Duerst, R. J., Smith, T. J. & Morrison, L. A. (2003). Herpes simplex virus type 2 virion host shutoff protein regulates alpha/beta interferon but not adaptive immune responses during primary infection in vivo. J Virol 77, 9337–9345.
24. Ning, S. (2011). Innate immune modulation in EBV infection. World J. Emergency Surg. Herpesviridae 2, 1.
25. Paludan, S. R., Bowie, A. G., Horan, K. A. & Fitzgerald, K. A. (2013). Recognition of herpesviruses by the innate immune system. Nat Rev Immunol 13, 614.
26. Park, R., El-Guindy, A., Heston, L., Lin, S. F., Yu, K. P., Nagy, M., Borah, S., Delecluse, H. J., Steitz, J. & Miller, G. (2014). Nuclear translocation and regulation of intranuclear distribution of cytoplasmic poly(A)-binding protein are distinct processes mediated by two Epstein Barr virus proteins. PLoS ONE 9, e92593.
27. Pasieka, T. J., Lu, B., Crosby, S. D., Wylie, K. M., Morrison, L. A., Alexander, D. E., Menachery, V. D. & Leib, D. A. (2008). Herpes simplex virus virion host shutoff attenuates establishment of the antiviral state. J Virol 82, 5527–5535.
28. + T cell recognition across all three phases of the lytic cycle. PLoS Pathog 10, e1004322.
29. Ressing, M. E., Keating, S. E., van Leeuwen, D., Koppers-Lalic, D., Pappworth, I. Y., Wiertz, E. J. H. J. & Rowe, M. (2005). Impaired transporter associated with antigen processing-dependent peptide transport during productive EBV infection. J Immunol 174, 6829–6838.
30. + T cell immunity via concerted actions of multiple gene products. Semin Cancer Biol 18, 397–408.
31. Rickinson, A. B. & Kieff, E. (2007). Epstein-Barr virus. In Field’s Virology, 5th edn, pp. 2655–2700. Edited by D. M. Knipe & P. M. Howley. Philadelphia: Lippincott Williams & Wilkins.
32. Rowe, M., Glaunsinger, B., van Leeuwen, D., Zuo, J., Sweetman, D., Ganem, D., Middeldorp, J., Wiertz, E. J. & Ressing, M. E. (2007). Host shutoff during productive Epstein–Barr virus infection is mediated by BGLF5 and may contribute to immune evasion. Proc Natl Acad Sci U S A 104, 3366–3371.
33. Sheridan, V., Polychronopoulos, L., Dutia, B. M. & Ebrahimi, B. (2014). A shutoff and exonuclease mutant of murine gammaherpesvirus-68 yields infectious virus and causes RNA loss in type I interferon receptor knockout cells. J Gen Virol 95, 1135–1143.
34. van Gent, M., Griffin, B. D., Berkhoff, E. G., van Leeuwen, D., Boer, I. G. J., Buisson, M., Hartgers, F. C., Burmeister, W. P., Wiertz, E. J. & Ressing, M. E. (2011). EBV lytic-phase protein BGLF5 contributes to TLR9 downregulation during productive infection. J Immunol 186, 1694–1702.
35. van Gent, M., Braem, S. G. E., de Jong, A., Delagic, N., Peeters, J. G. C., Boer, I. G. J., Moynagh, P. N., Kremmer, E., Wiertz, E. J. & other authors (2014). Epstein-Barr virus large tegument protein BPLF1 contributes to innate immune evasion through interference with Toll-like receptor signaling. PLoS Pathog 10, e1003960.
36. + T lymphocytes. Cell 77, 525–535.
37. + T cells through an additional host shutoff function. J Virol 82, 2385–2393.
38. Zuo, J., Currin, A., Griffin, B. D., Shannon-Lowe, C., Thomas, W. A., Ressing, M. E., Wiertz, E. J. H. J. & Rowe, M. (2009). The Epstein-Barr virus G-protein-coupled receptor contributes to immune evasion by targeting MHC class I molecules for degradation. PLoS Pathog 5, e1000255.